Europe Thrombosis And Hemostasis Biomarkers Market Size, Share & Industry Trends Analysis Report By Product, By Application, By End-use, By Location (Clinical Laboratory Tests, and Point-of-Care Tests), By Type, By Country and Growth Forecast, 2023 - 2030

The Europe Thrombosis And Hemostasis Biomarkers Market would witness market growth of 5.4% CAGR during the forecast period (2023-2030).

Venous thromboembolism includes pulmonary embolism (PE) and deep vein thrombosis (DVT). VTE poses a high risk of increased morbidity and death for the great majority of the population due to individual propensity to produce vascular thrombi, as well as clinical situations that further raise this propensity. VTE continues to be a major public health issue, and the general public and healthcare professionals need to be made more aware of it.

An estimated 1/1000 people have acute pulmonary embolism (aPE), one of the primary causes of mortality and morbidity. Within 90 days, there will likely be a 20% mortality rate for aPE. To lower the potential of recurrent venous thromboembolism occurrences, anticoagulation medication for at least 3 months is advised for patients with aPE. However, the odds of VTE recurrence among unprovoked patients with a first aPE are 10% at one year and 36% at ten years after quitting anticoagulant medication.

The Organization for Economic Co-operation and Development (OECD) estimates that in 2019, 32.3 million people in the Member States of the European Union had diabetes, an increase from previous estimates. This rise in prevalence goes hand in hand with the rising trends in bad diets, physical inactivity, socioeconomic deprivation, and obesity and overweight. These risk factors contribute not only to the development of diabetes but also to noncommunicable diseases (NCDs), such as cancer, cardiovascular disease, and chronic respiratory illness. This has prompted the governments of many Member States to introduce policies and initiatives to raise the prevalence of diabetes. Therefore, these precursors will aid the market's growth in the coming years.

The Germany market dominated the Europe Thrombosis And Hemostasis Biomarkers Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $493.7 million by 2030. The UK market is estimated to grow at a CAGR of 4.5% during (2023 - 2030). Additionally, The France market would experience witness a CAGR of 6.2% during (2023 - 2030).

Based on Product, the market is segmented into Reagents & Consumables, and Analyzers. Based on Application, the market is segmented into Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Disseminated Intravascular Coagulation (DIC) & Others. Based on End-use, the market is segmented into Diagnostic Centers, Hospitals & Clinics, and Academic & Research Institutes and Others. Based on Location, the market is segmented into Clinical Laboratory Tests, and Point-of-Care Tests. Based on Type, the market is segmented into Post-Thrombin (PT), Activated Partial Thromboplastin Time (APTT) Test, D-Dimer, Anti-Thrombin III, Plasminogen & Fibrinogen, Soluble Fibrin, Selectins, Factor VIII, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Worldwide Thrombosis And Hemostasis Biomarkers Market is Projected to reach USD 7.4 Billion by 2030, at a CAGR of 5.6%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Siemens Healthineers AG (Siemens AG), Abbott Laboratories, BioMérieux S.A., Horiba Ltd., QuidelOrtho Corporation, Werfen, S.A., Diazyme Laboratories, Inc. (General Atomics) and BioMedica Diagnostics Inc. (Scotia Investments Family of Companies).

Scope of the Study

Market Segments Covered in the Report:

By Product

• Reagents & Consumables
• Analyzers

By Application

• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Disseminated Intravascular Coagulation (DIC) & Others

By End-Use

• Diagnostic Centers
• Hospitals & Clinics
• Academic & Research Institutes and Others

By Location

• Clinical Laboratory Tests
• Point-of-Care Tests

By Type

• Post-Thrombin (PT)
• Activated Partial Thromboplastin Time (APTT) Test
• D-Dimer
• Anti-Thrombin III
• Plasminogen & Fibrinogen
• Soluble Fibrin
• Selectins
• Factor VIII
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Thermo Fisher Scientific, Inc.
• F. Hoffmann-La Roche Ltd.
• Siemens Healthineers AG (Siemens AG)
• Abbott Laboratories
• BioMérieux S.A.
• Horiba Ltd.
• QuidelOrtho Corporation
• Werfen, S.A.
• Diazyme Laboratories, Inc. (General Atomics)
• BioMedica Diagnostics Inc. (Scotia Investments Family of Companies)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Thrombosis And Hemostasis Biomarkers Market, by Product
1.4.2 Europe Thrombosis And Hemostasis Biomarkers Market, by Application
1.4.3 Europe Thrombosis And Hemostasis Biomarkers Market, by End-Use
1.4.4 Europe Thrombosis And Hemostasis Biomarkers Market, by Location
1.4.5 Europe Thrombosis And Hemostasis Biomarkers Market, by Type
1.4.6 Europe Thrombosis And Hemostasis Biomarkers Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Thrombosis And Hemostasis Biomarkers Market by Product
3.1 Europe Reagents & Consumables Market by Country
3.2 Europe Analyzers Market by Country

Chapter 4. Europe Thrombosis And Hemostasis Biomarkers Market by Application
4.1 Europe Deep Vein Thrombosis (DVT) Market by Country
4.2 Europe Pulmonary Embolism (PE) Market by Country
4.3 Europe Disseminated Intravascular Coagulation (DIC) & Others Market by Country

Chapter 5. Europe Thrombosis And Hemostasis Biomarkers Market by End-use
5.1 Europe Diagnostic Centers Market by Country
5.2 Europe Hospitals & Clinics Market by Country
5.3 Europe Academic & Research Institutes and Others Market by Country

Chapter 6. Europe Thrombosis And Hemostasis Biomarkers Market by Location
6.1 Europe Clinical Laboratory Tests Market by Country
6.2 Europe Point-of-Care Tests Market by Country

Chapter 7. Europe Thrombosis And Hemostasis Biomarkers Market by Type
7.1 Europe Post-Thrombin (PT) Market by Country
7.2 Europe Activated Partial Thromboplastin Time (APTT) Test Market by Country
7.3 Europe D-Dimer Market by Country
7.4 Europe Anti-Thrombin III Market by Country
7.5 Europe Plasminogen & Fibrinogen Market by Country
7.6 Europe Soluble Fibrin Market by Country
7.7 Europe Selectins Market by Country
7.8 Europe Factor VIII Market by Country
7.9 Europe Others Market by Country

Chapter 8. Europe Thrombosis And Hemostasis Biomarkers Market by Country
8.1 Germany Thrombosis And Hemostasis Biomarkers Market
8.1.1 Germany Thrombosis And Hemostasis Biomarkers Market by Product
8.1.2 Germany Thrombosis And Hemostasis Biomarkers Market by Application
8.1.3 Germany Thrombosis And Hemostasis Biomarkers Market by End-use
8.1.4 Germany Thrombosis And Hemostasis Biomarkers Market by Location
8.1.5 Germany Thrombosis And Hemostasis Biomarkers Market by Type
8.2 UK Thrombosis And Hemostasis Biomarkers Market
8.2.1 UK Thrombosis And Hemostasis Biomarkers Market by Product
8.2.2 UK Thrombosis And Hemostasis Biomarkers Market by Application
8.2.3 UK Thrombosis And Hemostasis Biomarkers Market by End-use
8.2.4 UK Thrombosis And Hemostasis Biomarkers Market by Location
8.2.5 UK Thrombosis And Hemostasis Biomarkers Market by Type
8.3 France Thrombosis And Hemostasis Biomarkers Market
8.3.1 France Thrombosis And Hemostasis Biomarkers Market by Product
8.3.2 France Thrombosis And Hemostasis Biomarkers Market by Application
8.3.3 France Thrombosis And Hemostasis Biomarkers Market by End-use
8.3.4 France Thrombosis And Hemostasis Biomarkers Market by Location
8.3.5 France Thrombosis And Hemostasis Biomarkers Market by Type
8.4 Russia Thrombosis And Hemostasis Biomarkers Market
8.4.1 Russia Thrombosis And Hemostasis Biomarkers Market by Product
8.4.2 Russia Thrombosis And Hemostasis Biomarkers Market by Application
8.4.3 Russia Thrombosis And Hemostasis Biomarkers Market by End-use
8.4.4 Russia Thrombosis And Hemostasis Biomarkers Market by Location
8.4.5 Russia Thrombosis And Hemostasis Biomarkers Market by Type
8.5 Spain Thrombosis And Hemostasis Biomarkers Market
8.5.1 Spain Thrombosis And Hemostasis Biomarkers Market by Product
8.5.2 Spain Thrombosis And Hemostasis Biomarkers Market by Application
8.5.3 Spain Thrombosis And Hemostasis Biomarkers Market by End-use
8.5.4 Spain Thrombosis And Hemostasis Biomarkers Market by Location
8.5.5 Spain Thrombosis And Hemostasis Biomarkers Market by Type
8.6 Italy Thrombosis And Hemostasis Biomarkers Market
8.6.1 Italy Thrombosis And Hemostasis Biomarkers Market by Product
8.6.2 Italy Thrombosis And Hemostasis Biomarkers Market by Application
8.6.3 Italy Thrombosis And Hemostasis Biomarkers Market by End-use
8.6.4 Italy Thrombosis And Hemostasis Biomarkers Market by Location
8.6.5 Italy Thrombosis And Hemostasis Biomarkers Market by Type
8.7 Rest of Europe Thrombosis And Hemostasis Biomarkers Market
8.7.1 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Product
8.7.2 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Application
8.7.3 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by End-use
8.7.4 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Location
8.7.5 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Type

Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Siemens Healthineers AG (Siemens AG)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.3.6 SWOT Analysis
9.4 Abbott Laboratories
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 BioMérieux S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.6 Horiba Ltd.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional & Segmental Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.7 QuidelOrtho Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.8 Werfen, S.A.
9.8.1 Company Overview
9.9 Diazyme Laboratories, Inc. (General Atomics)
9.9.1 Company Overview
9.1 BioMedica Diagnostics Inc. (Scotia Investments Family of Companies)
9.10.1 Company Overview

TABLE 1 Europe Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
TABLE 2 Europe Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
TABLE 3 Europe Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
TABLE 4 Europe Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
TABLE 5 Europe Reagents & Consumables Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Reagents & Consumables Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe Analyzers Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Analyzers Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
TABLE 10 Europe Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
TABLE 11 Europe Deep Vein Thrombosis (DVT) Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe Deep Vein Thrombosis (DVT) Market by Country, 2023 - 2030, USD Million
TABLE 13 Europe Pulmonary Embolism (PE) Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Pulmonary Embolism (PE) Market by Country, 2023 - 2030, USD Million
TABLE 15 Europe Disseminated Intravascular Coagulation (DIC) & Others Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Disseminated Intravascular Coagulation (DIC) & Others Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
TABLE 18 Europe Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
TABLE 19 Europe Diagnostic Centers Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Diagnostic Centers Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 23 Europe Academic & Research Institutes and Others Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Academic & Research Institutes and Others Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
TABLE 26 Europe Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
TABLE 27 Europe Clinical Laboratory Tests Market by Country, 2019 - 2022, USD Million
TABLE 28 Europe Clinical Laboratory Tests Market by Country, 2023 - 2030, USD Million
TABLE 29 Europe Point-of-Care Tests Market by Country, 2019 - 2022, USD Million
TABLE 30 Europe Point-of-Care Tests Market by Country, 2023 - 2030, USD Million
TABLE 31 Europe Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
TABLE 32 Europe Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
TABLE 33 Europe Post-Thrombin (PT) Market by Country, 2019 - 2022, USD Million
TABLE 34 Europe Post-Thrombin (PT) Market by Country, 2023 - 2030, USD Million
TABLE 35 Europe Activated Partial Thromboplastin Time (APTT) Test Market by Country, 2019 - 2022, USD Million
TABLE 36 Europe Activated Partial Thromboplastin Time (APTT) Test Market by Country, 2023 - 2030, USD Million
TABLE 37 Europe D-Dimer Market by Country, 2019 - 2022, USD Million
TABLE 38 Europe D-Dimer Market by Country, 2023 - 2030, USD Million
TABLE 39 Europe Anti-Thrombin III Market by Country, 2019 - 2022, USD Million
TABLE 40 Europe Anti-Thrombin III Market by Country, 2023 - 2030, USD Million
TABLE 41 Europe Plasminogen & Fibrinogen Market by Country, 2019 - 2022, USD Million
TABLE 42 Europe Plasminogen & Fibrinogen Market by Country, 2023 - 2030, USD Million
TABLE 43 Europe Soluble Fibrin Market by Country, 2019 - 2022, USD Million
TABLE 44 Europe Soluble Fibrin Market by Country, 2023 - 2030, USD Million
TABLE 45 Europe Selectins Market by Country, 2019 - 2022, USD Million
TABLE 46 Europe Selectins Market by Country, 2023 - 2030, USD Million
TABLE 47 Europe Factor VIII Market by Country, 2019 - 2022, USD Million
TABLE 48 Europe Factor VIII Market by Country, 2023 - 2030, USD Million
TABLE 49 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 50 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 51 Europe Thrombosis And Hemostasis Biomarkers Market by Country, 2019 - 2022, USD Million
TABLE 52 Europe Thrombosis And Hemostasis Biomarkers Market by Country, 2023 - 2030, USD Million
TABLE 53 Germany Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
TABLE 54 Germany Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
TABLE 55 Germany Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
TABLE 56 Germany Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
TABLE 57 Germany Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
TABLE 58 Germany Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
TABLE 59 Germany Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
TABLE 60 Germany Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
TABLE 61 Germany Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
TABLE 62 Germany Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
TABLE 63 Germany Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
TABLE 64 Germany Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
TABLE 65 UK Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
TABLE 66 UK Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
TABLE 67 UK Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
TABLE 68 UK Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
TABLE 69 UK Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
TABLE 70 UK Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
TABLE 71 UK Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
TABLE 72 UK Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
TABLE 73 UK Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
TABLE 74 UK Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
TABLE 75 UK Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
TABLE 76 UK Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
TABLE 77 France Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
TABLE 78 France Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
TABLE 79 France Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
TABLE 80 France Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
TABLE 81 France Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
TABLE 82 France Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
TABLE 83 France Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
TABLE 84 France Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
TABLE 85 France Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
TABLE 86 France Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
TABLE 87 France Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
TABLE 88 France Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
TABLE 89 Russia Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
TABLE 90 Russia Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
TABLE 91 Russia Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
TABLE 92 Russia Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
TABLE 93 Russia Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
TABLE 94 Russia Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
TABLE 95 Russia Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
TABLE 96 Russia Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
TABLE 97 Russia Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
TABLE 98 Russia Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
TABLE 99 Russia Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
TABLE 100 Russia Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
TABLE 101 Spain Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
TABLE 102 Spain Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
TABLE 103 Spain Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
TABLE 104 Spain Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
TABLE 105 Spain Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
TABLE 106 Spain Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
TABLE 107 Spain Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
TABLE 108 Spain Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
TABLE 109 Spain Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
TABLE 110 Spain Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
TABLE 111 Spain Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
TABLE 112 Spain Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
TABLE 113 Italy Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
TABLE 114 Italy Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
TABLE 115 Italy Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
TABLE 116 Italy Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
TABLE 117 Italy Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
TABLE 118 Italy Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
TABLE 119 Italy Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
TABLE 120 Italy Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
TABLE 121 Italy Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
TABLE 122 Italy Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
TABLE 123 Italy Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
TABLE 124 Italy Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
TABLE 125 Rest of Europe Thrombosis And Hemostasis Biomarkers Market, 2019 - 2022, USD Million
TABLE 126 Rest of Europe Thrombosis And Hemostasis Biomarkers Market, 2023 - 2030, USD Million
TABLE 127 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2022, USD Million
TABLE 128 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Product, 2023 - 2030, USD Million
TABLE 129 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2022, USD Million
TABLE 130 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Application, 2023 - 2030, USD Million
TABLE 131 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2022, USD Million
TABLE 132 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by End-use, 2023 - 2030, USD Million
TABLE 133 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2022, USD Million
TABLE 134 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Location, 2023 - 2030, USD Million
TABLE 135 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2022, USD Million
TABLE 136 Rest of Europe Thrombosis And Hemostasis Biomarkers Market by Type, 2023 - 2030, USD Million
TABLE 137 Key Information – Thermo Fisher Scientific, Inc.
TABLE 138 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 139 Key Information – Siemens Healthineers AG
TABLE 140 Key Information – Abbott Laboratories
TABLE 141 Key information – BioMérieux S.A.
TABLE 142 key Information – Horiba Ltd.
TABLE 143 key information – QuidelOrtho Corporation
TABLE 144 Key Information – Werfen, S.A.
TABLE 145 Key Information – Diazyme Laboratories, Inc.
TABLE 146 Key Information – BioMedica Diagnostics Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Thrombosis And Hemostasis Biomarkers Market share by Product, 2022
FIG 3 Europe Thrombosis And Hemostasis Biomarkers Market share by Product, 2030
FIG 4 Europe Thrombosis And Hemostasis Biomarkers Market by Product, 2019 - 2030, USD Million
FIG 5 Europe Thrombosis And Hemostasis Biomarkers Market share by Application, 2022
FIG 6 Europe Thrombosis And Hemostasis Biomarkers Market share by Application, 2030
FIG 7 Europe Thrombosis And Hemostasis Biomarkers Market by Application, 2019 - 2030, USD Million
FIG 8 Europe Thrombosis And Hemostasis Biomarkers Market share by End-use, 2022
FIG 9 Europe Thrombosis And Hemostasis Biomarkers Market share by End-use, 2030
FIG 10 Europe Thrombosis And Hemostasis Biomarkers Market by End-use, 2019 - 2030, USD Million
FIG 11 Europe Thrombosis And Hemostasis Biomarkers Market share by Location, 2022
FIG 12 Europe Thrombosis And Hemostasis Biomarkers Market share by Location, 2030
FIG 13 Europe Thrombosis And Hemostasis Biomarkers Market by Location, 2019 - 2030, USD Million
FIG 14 Europe Thrombosis And Hemostasis Biomarkers Market share by Type, 2022
FIG 15 Europe Thrombosis And Hemostasis Biomarkers Market share by Type, 2030
FIG 16 Europe Thrombosis And Hemostasis Biomarkers Market by Type, 2019 - 2030, USD Million
FIG 17 Europe Thrombosis And Hemostasis Biomarkers Market share by Country, 2022
FIG 18 Europe Thrombosis And Hemostasis Biomarkers Market share by Country, 2030
FIG 19 Europe Thrombosis And Hemostasis Biomarkers Market by Country, 2019 - 2030, USD Million
FIG 20 Swot analysis: thermo fisher scientific, inc.
FIG 21 Swot analysis: Siemens AG
FIG 22 Swot analysis: Abbott laboratories